Pathology

Andrew M. Bellizzi, MD

Portrait

Co-Director of Immunopathology Laboratory
Co-Director of GI Pathology, Holden Comprehensive Cancer Ctr
Clinical Associate Professor of Pathology  - Anatomic Pathology

Contact Information

Primary Office: 5239-A Roy Carver Pavilion
Iowa City, IA 52242
Primary Office Phone: 319-356-4436

Email: andrew-bellizzi@uiowa.edu

Education

BA, University of Notre Dame
BS, University of Notre Dame
MD, Northwestern University, Feinberg School of Medicine

Residency, AP/CP, University of Virginia Health System
Fellowship, Gastrointestinal/Liver Pathology, The Ohio State University Medical Center

Licensure and Certifications

State of Iowa Medical License Iowa Board of Medicine
Anatomic and Clinical Pathology American Board of Pathology

Research Summary

Interests: Diagnosis, classification, and etiopathogenesis of human disease (especially gastrointestinal, neuroendocrine, hereditary, liver, and pancreatobiliary).

Center, Program and Institute Affiliations

Holden Comprehensive Cancer Center

All Publications

Bellizzi A, Hornick J.  Diseases of the stomach.  Cambridge University Press.  2015 May 31. 

Bellizzi A.  Screening for Lynch Syndrome: A No-Brainer: BRAF V600E Mutation-Specific Immunohistochemistr: Caveat Emptor.  Am J Clin Pathol.  2015 March. 143(3):320-4.
[PubMed]

O'Leary B, Fath M, Bellizzi A, Hrabe J, Button A, Allen B, Case A, Altekruse S, Wagner B, Buettner G, Lynch C, Hernandez B, Cozen W, Beardsley R, Keene J, Henry M, Domann F, Spitz D, Mezhir J.  Loss of SOD3 (EcSOD) expression promotes an aggressive phenotype in human pancreatic ductal adenocarcinoma.  Clin Cancer Res;  2015. 

Sherman S, Maxwell J, Carr J, Wang D, Bellizzi A, O'dorisio S, O'Dorisio T, Howe J.  Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.  Clin Exp Metastasis.  2014 December. 31(8):935-44.
[PubMed]

Hagen J, Muniz V, Falls K, Reed S, Taghiyev A, Quelle F, Gourronc F, Klingelhutz A, Major H, Askeland R, Sherman S, O'Dorisio T, Bellizzi A, Howe J, Darbro B, Quelle D.  RABL6A promotes G1-S phasae progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner.  Cancer Res.  2014 November 15. 74(22):6661-70.
[PubMed]

Wojcik J, Bellizzi A, Dal C, Bredella M, Fletcher C, Hornicek F, Deshpande V, Hornick J, Nielsen G.  Primary sclerosing epithelioid fibrosarcoma of bone: Analysis of a series.  Am J Surg Pathol.  2014 November. 38(11):1538-44.
[PubMed]

Gailey M, Bellizzi A.  Comprehensive evaluation of the urothelial carcinoma markers GATA3 and S100P in squamous cell carcinoma .  2014 United States and Canadian Academy of Pathology Annual Meeting.  2014 4th Quarter. 

Maxwell J, O'Dorisio T, Bellizzi A, Howe J.  Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association?.  Pancreas.  2014 May. 43(4):651-6.
[PubMed]

Basturk O, Hruban R, Adsay N, Krasinskas A, Yang Z, LaRosa S, Jang K, Tang L, Vakiani E, Frankel W, Liu X, Zhang L, Giordano T, Bellizzi A, Chen J, Shi C, Wolfgang C, Rezaee N, Saka B, Deshpande V, Klimstra D.  Poorly differentiated neuroendocrine carcinomas of the pancreas: A clinicopathologic analysis of 54 cases.  Am J Surg Pathol.  2014 April. 38(4):437-47.
[PubMed]

Lee L, Wu B, Banks P, Kadiyala V, Mehta S, Saltzman J, Thompson C, Bellizzi A.  Utility of commercial DNA analysis in detecting malignancy within pancreatic cysts.  JOP.  2014 March 10. 15(2):182-8.
[PubMed]

Gailey M, Bellizzi A, Jensen C.  Differentiating small cell carcinoma from squamous cell carcinioma on fine needle aspiration: a head-to-head comparison of p40 and p63 using cell block immunocytochemistry.  2014 United States and Canadian Academy of Pathology Annual Meeting.  2014 March. 

Stashek K, Czeczok T, Bellizzi A.  Extensive evaluation of immunohistochemistry to assign site of origin in well-differentiated neuroendocrine tumors: a study of 10 markers in 265 tumors.  2014 United States and Canadian Academy of Pathology Annual Meeting.  2014 March. 

Czeczok T, Hornick J, Bellizzi A.  Immunohistochemistry for Merkel cell polyomavirus large T antigen (CM2B4) and neurofilament protein adds little value to CK20 and TTF-1 in the distinction of cutaenous and visceral high-grade neuroendorine carcinomas.  2014 United States and Canadian Academy of Pathology Annual Meeting.  2014 March. 

Gailey M, Guseva N, Milhem M, Miller B, Miller M, Bellizzi A, Henry M, Ma D.  Molecular and immunohistochemical profiling of leiomyosarcomas.  2014 United States and Canadian Academy of Pathology Annual Meeting.  2014 March. 

Wojcik J, Hornick J, Bellizzi A, Fletcher C, Nielsen G.  Primary sclerosing epithelioid fibrosarcomas of bone: analysis of a series.  2014 United States and Canadian Academy of Pathology Annual Meeting.  2014 March. 

Maxwell J, Sherman S, Stashek K, O'Dorisio T, Bellizzi A, Howe J.  A practical method to determine site of unknown primary in metastatic neuroendocrine tumors.  2014 American Association of Endocrine Surgeons Annual Meeting.  2014. 

McMullen E, Maxwell J, Bellizzi A.  Evaluation of SATB2 in neuroendocrine tumors reveals a gradient of expression from hindgut to foregut.  2014 American Societ of Clinical Pathology Annual Meeting.  2014. 

Samuelson M, Stelow E, Hornick J, Bellizzi A.  Frequent nuclear β-catenin expression in adrenal cortical carcinoma: a diagnostic pitfall.  2014 United States and Canadian Academy of Pathology Annual Meeting.  2014. 

Czeczok T, Gailey M, Hornick J, Bellizzi A.  High-grade neuroendocrine carcinomas are characterized by marked transcription factor lineage infidelity: an evaluation of 36 diagnostic markers in 83 tumors.  2014 United States and Canandian Academy of Pathology Annual Meeting.  2014. 

Wood S, Czeczok T, Stashek K, Bellizzi A.  Re-evaluation of the significance of sustentacular cells in neuroendocrine tumors with the new age marker SOX10.  2014 American Society of Clinical Pathology Annual Meeting.  2014. 

Hitt S, Czeczok T, Darbro B, Stashek K, Bellizzi A.  Results of SMAD4 immunohistochemistry in well-differentiated neuroendocrine tumors reflects relative specificity of chromosome 18 losses for jejunoileal origin.  2014 College of American Pathology Annual Meeting.  2014. 

Savage E, Gailey M, Bellizzi A.  Squamous cell carcinomas frequently stain positively for the 'adenocarcinoma-marker" MOC-31: a diagnostic pitfall.  2014 United States and Canadian Academy of Pathology Annual Meeting.  2014. 

Mezhir J, O'Leary B, Bellizzi A, Altekruse S, Lynch C, Hernandez B, Cohen W, Henry M, Keene J, Beardsley R, Spitz D, Domann F.  The role of extracelllar superoxide dismutase activity in pancreatic cancer biology and therapy.  2014 American Association of Cancer Research .  2014. 

Chintaparthi J, Chandran P, Buckwalter J, Bellizzi A, McNeely P, Dillon J.  Tumor-induced osteomalacia diagnosed with 68-Ga DOTATOC PET san and successfully treated surgially.  2014 International Society of Endocrinology/The Endocrine Society Annual Meeting.  2014. 

Ma D, Stence A, Bossler A, Hackman J, Bellizzi A.  Identification of KIT activating mutations in paediatric solitary mastocytoma.  Histopathology.  2014 January. 64(2):218-25.
[PubMed]

Gailey M, Bellizzi A.  Immunohistochemistry for the novel markers glypican 3, PAX8 and p40 (ΔNp63) in squamous cell and urothelial carcinoma.  Am J Clin Pathol.  2013 December. 140(6):872-80.
[PubMed]

Carr J, Sherman S, Wang D, Dahdaleh F, Bellizzi A, O'Dorisio M, O'Dorisio T, Howe J.  Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors.  Ann Surg Oncol.  2013 December. suppl 3:S739-46.
[PubMed]

Bellizzi A.  Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms.  Semin Diagn Pathol.  2013 November. 30(4):329-61.
[PubMed]

Appelman H, Streutker C, Vieth M, Neumann H, Neurath M, Upton M, Sagaert X, Wang H, El-Zimaity H, Abraham S, Bellizzi A.  The esophageal mucosa and submuocsa: immunohistology in GERD and Barrett's esophagus.  Ann NY Acad Sci.  2013 October. 1300(1):144-165.
[PubMed]

Bellizzi A, Nardone G, Compare D, Bor S, Capanoglu D, Farrė R, Neumann H, Neurath M, Vieth M, Chen H, Chen X.  Tissue resistance in the normal and diseased esophagus.  Ann N Y Acad Sci.  2013 October. 1300(1):200-212.
[PubMed]

Bellizzi A.  Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry.  Adv Anat Pathol.  2013 September. 20(5):285-314.
[PubMed]

Lewis G, Wang H, Bellizzi A, Klein A, Askin F, Schwartz L, Schulick R, Wolfgang C, Cameron J, O'Reilly E, Yu K, Hruban R.  Prognosis of Minimally Invasive Carcinoma Arising in Mucinous Cystic Neoplasms of the Pancreas.  Am J Surg Pathol.  2013 April. 47(4):601-605.
[PubMed]

Steussy B, Bellizzi A.  BRAF-mutant colon cancers with and without high-level microsatellite instability are distinguished by histology and methylation phenotype.  2013 United States and Canadian Academy of Pathology Annual Meeting.  2013 March. 

Basturk O, Hruban R, Adsay V, Krasinskas A, JAng K, Liu X, Vakiani E, Zhang L, Frankel W, Giordano T, Bellizzi A, Chen J, Desphande V, Yang Z, Klimstra D.  High-grade neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 60 cases.  2013 United States and Canadian Academy of Pathology Annual Meeting.  2013 March. 

Basturk O, Yang Z, Tang L, Hruban R, McCall C, Adsay V, Krasinskas A, Jang K, Bellizzi A, Shi C, Klimstra D.  Increased (>20%) Ki67 proliferation index in morphologically well differentiated pancreatic neuroendocrine tumors (PanNETs) correlates with decreased overall survival.  2013 United States and Canadian Academy of Pathology Annual Meeting.  2013 March. 

Stashek K, Mezhir J, Roggin K, Bellizzi A.  SMAD4 expression in mucin-producing cystic neoplasms and associated carcinomas.  2013 United States and Canadian Academy of Pathology Annual Meeting.  2013 March. 

Wilson T, Bellizzi A.  Chemoradiotherapy-associated psuedotumor: a diagnostic consideration in frozen section biopsies of liver lesions in patients undergoing a cancer operation.  2013 College of American Pathology Annual Meeting.  2013. 

Seidman M, Bellizzi A.  Combined Foxp3 and IgG4 staining reveal distinct subsets of inflammatory bowel disease.  2013 American Society for Investicative Patholog Annual Meeting.  2013. 

Bellizzi A.  Merkel cell carcinoma is caused by a polyomavirus, which can be detected by routine immunohistochemistry.  PathBeat: The Newsletter of the Department of Pathology, University of Iowa Carver College of Medicine.  2013. 

Bellizzi A.  University of Iowa Health Care launches universal screening for Lynch syndrome in colorectal cancer.  PathBeat: The Newsletter of the Department of Pathology, University of Iowa Carver College of Medicine.  2013. 

Bellizzi A.  Updates in diagnostic immunohistochemistry: expanded offerings from the University of Iowa Immunopathology Laboratory.  PathBeat: The Newsletter of the Department of Pathology, University of Iowa Carver College of Medicine.  2013. 

Rodig S, Cheng J, Wardzala J, DoRosario A, Scanlon J, Laga A, Martinez-Fernandez A, Barletta J, Bellizzi A, Sadasivam S, Holloway D, Cooper D, Kupper T, Wang L, Decaprio J.  Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus.  J Clin Invest.  2012 December 3. 122(12):4645-53.

Lee L, Banks P, Bellizzi A, Sainani N, Kadiyala V, Suleiman S, Conwell D, Paulo J.  Inflammatory protein profiling of pancreatic cyst fluid using EUS-FNA in tandem with cytokine microarray differentiates between branch duct IPMN and inflammatory cysts.  J Immunol Methods.  2012 August 31. 382(2-Jan):142-9.
[PubMed]

Bellizzi A.  Gastrointestinal and liver pathology.  Am J Surg Pathol.  2012 July. 36(7):1104-5.

Bellizzi A.  Gastrointestinal and Liver Pathology.  Am J Surg Pathol.  2012 July. 36(7):1104-5.

Patel B, Mottola J, Sahni V, Cantisani V, Ertruk M, Friedman S, Bellizzi A, Marcantonio A, Mortele K.  MDCT assessment of ulcerative colitis: radiologic analysis with clinical, endoscopic, and pathologic correlation.  Abdom Imaging.  2012 February. 37(1):61-9.
[PubMed]

Lee L, Szafranska-Schwarzbach A, Wylie D, Doyle L, Bellizzi A, Kadiyala V, Suleiman S, Kemppainen J, Kincaid A, Houghton J, McGee S, Sah S, Banks P, Andruss B, Conwell D.  Differential expression of DNA mutations in k-ras and GNAS in pancreatic cystic neoplasms.  2012 American College of Gastroenterology Annual Scientific Meeting.  2012. 

Lee L, Bellizzi A, Banks P, Sainani N, Kadiyala V, Suleiman S, Conwell D, Paulo J.  Differentiating branch duct and mixed IPMN in endoscopically collected pancreatic cyst fluid cytokine analysis.  2012 American College of Gastroenterology Annual Scientific Meeting.  2012. 

Lee L, Bellizzi A, Banks P, Sainani N, Kadiyala V, Suleiman S, Conwell D, Paulo J.  Differentiating branch duct and mixed IPMN in endoscopically collected pancreatic cyst fluid via cytokine analysis..  Gastroenterol Res Pract.  2012. 2012:247-309.
[PubMed]

Bellizzi A, Soriano G, Herrera A, Marty F, Hornick J.  Histopathology of "Cord Colitis Syndrome" in umbilical cord blood transplant receipients.  2012 United States and Canadian Academy of Pathology Annual Meeting.  2012. 

Ma D, Stence A, Hackman J, Pruessner J, Buhay J, Forde S, Zubcic M, Bellizzi A, Heusel J, Bossler A.  Identification of KIT activating mutations in pediatric solitary mastocytoma.  American Association for Molecular Pathology Annual Meeting.  2012. 

Gailey M, Bellizzi A.  Immunohistochemistry for novel markers in squamous cell carcinoma: glypican-3 is expressed across anatomic sites, PAX8 is limited in distribution and p40 is extrremely sensitive.  2013 United States and Canadian Academy of Pathology Annual Meeting.  2012. 

Lee L, Szafranska-Schwarzbach A, Wylie D, Bellizzi A, Doyle L, Kadiyala V, Suleiman S, Kemppainen J, Kincaid A, Houghton J, McGee S, Sah S, Banks P, Andruss B, Conwell D.  Investigation of MicroRNA in pancreatic cystic tumors (IMPACT) study: differential expression observed among pancreatic cystic neoplasms.  2012 American College of Gastroenterology Annual Scientific Meeting.  2012. 

Shinagare A, Ramaiya N, Bellizzi A, Mayer R.  Locally advanced anaplastic pancreatic adenocarcinoma with initial response to FOLFIRINOX and rapid progression after five months.  Pancreatology.  2012 January. 12(1):35-8.
[PubMed]

Barletta J, Bellizzi A, Hornick J.  Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome.  Am J Surg Pathol.  2011 October. 35(10):1505-11.
[PubMed]

Lightdale C, Degl'Innocenti D, Bellizzi A, Ishimura N, Amano Y, Appelman H, Penagini R, Tenca A, Falk G, Wong R, Gerson L, Ramirez F, Horwhat J, Lightdale C, DeVault K, Freschi G, Taddei A, Bechi P, Ringressi M, Castiglione F, Rossi Degl'Innocenti D, Wang H, Huang Q, Bellizzi A, Lisovsky M, Srivastava A, Riddell R, Johnson L, Saunders M, Chuttani R.  Barrett's esophagus: endoscopic diagnosis.  Annals of the New York Academy of Sciences.  2011 September. 1232:53-75.
[PubMed]

Bellizzi A, Fang D, Das K, Cao W, Malhotra U, Triadafilopoulos G, Najarian R, Hardie L, Lightdale C, Beales I, Felix V, Schneider P, Bellizzi A.  Barrett's esophagus: progression to adenocarcinoma and markers.  Ann N Y Acad Sci.  2011 September. 1232:210-29.
[PubMed]

Herrera A, Soriano G, Bellizzi A, Hornick J, Ho V, Ballen K, Baden L, Cutler C, Antin J, Soiffer R, Marty F.  Cord colitis syndrome in cord-blood stem-cell transplantation.  N Engl J Med.  2011 September. 365(9):815-24.
[PubMed]

Wang X, Ouyang H, Yamamoto Y, Kumar P, Wei T, Dagher R, Vincent M, Lu X, Bellizzi A, Ho K, Crum C, Xian W, McKeon F.  Residual embryonic cells as precursors of a Barrett's-like metaplasia.  Cell.  2011 June. 145(7):1023-35.
[PubMed]

Bellizzi A, LeGallo R, Boyd J, Iezzoni J.  Hepatocyte cytokeratin 7 expression in chronic allograft rejection.  Am J Clin Pathol.  2011 February. 135(2):238-44.
[Link]

Barletta J, Bellizzi A, Hornick J.  Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome.  2011 United States and Canadian Academy of Pathology Annual Meeting.  2011. 

Rege T, King E, Barletta J, Bellizzi A.  Ki-67 proliferation index in pancreatic endocrine tumors: comparison with mitotic count, interobserver variability, and impact on grading.  2011 United States and Canadian Academy of Pathology Annual Meeting.  2011. 

Baez J, Hamilton M, Bellizzi A, Mortelé K.  Gastric involvement in autoimmune pancreatitis: MDCT and histopathologic features.  JOP.  2010 November 9. 11(6):610-3.
[Link]

Woodford R, Nikiforov Y, Hunt J, Bellizzi A, Zhang X, Mills S, Stelow E.  Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.  Am J Surg Pathol.  2010 November. 34(11):1582-90.
[Link]

Bellizzi A, Bloomston M, Zhou X, Iwenofu O, Frankel W.  The mTOR pathway is frequently activated in pancreatic ductal adenocarcinoma and chronic pancreatitis.  Appl Immunohistochem Mol Morphol.  2010 October. 18(5):442-7.
[Link]

Bass C, Meyerhoff K, Damon A, Bellizzi A, Salzar R, Rafaels K.  Drosophila melanogaster larvae as a model for blast lung injury.  J Trauma.  2010 July. 69(1):179-84.
[Link]

Bellizzi A, Odze R.  Histopathology of Barrett's esophagus: a review for the practicing gastroenterologist.  Tech Gastrointest Endosc.  2010 April. 12(2):69-81.

Bellizzi A, Rock J, Marsh W, Frankel W.  Serrated lesions of the appendix: a morphologic and immunohistochemical appraisal.  Am J Clin Pathol.  2010 April. 133(4):623-32.
[Link]

Liu J, Bellizzi A, Hatzaras I, Bloomston M, Frankel W.  Esophageal adenocarcinoma shows upregulation of Skp2 and Cks1 and downregulation of p27.  2010 United States and Canadian Academy of Pathology Annual Meeting.  2010. 

Crowder C, Iwenofu O, Bellizzi A, Frankel W.  Frequent activation of the mTOR pathway in adenocarcinoma of the ampulla of vater.  2010 United States and Canadian Academy of Pathology Annual Meeting.  2010. 

Crowder C, Sweet K, Bellizzi A, Frankel W.  Hyperplastic polyposis syndrome is an underdiagnosed and unclear entity: an opportunity for the surgical pathologist?.  2010 United States and Canadian Academy of Pathology Annual Meeting.  2010. 

Bellizzi A, Crowder C, Marsh W, Hampel H, Frankel W.  Mismatch repair status in a cohort of rectal adenocarcinoma before and after chemoradiation.  2010 United States and Canadian Academy of Pathology Annual Meeting.  2010. 

Frankel W, Liu J, Hampel H, Bellizzi A.  Mismatch repair status in seventy biliary tract carcinomas.  2010 United States and Canadian Academy of Pathology Annual Meeting.  2010. 

Humphrey P, Bellizzi A, Mortele K.  Multimodality imaging features of pancreatic endocrine tumors (PET).  2010 Canadian Assoiciation of Radiologists Annual Meeting.  2010. 

Bellizzi A, Crowder C, Marsh W, Hampel H, Frankel W.  Treated rectal adenocarcinomas are associated with increased expression of CK20 and chromogranin.  2010 United States and Canadian Academy of Pathology Annual Meeting.  2010. 

Bellizzi A, Bruzzi C, French C, Stelow E.  The cytologic features of NUT midline carcinoma.  Cancer.  2009 December 25. 117(6):508-15.
[Link]

West A, Bellizzi A, Bolton W.  A case of beign "double-positive" (anti-GBM/ANCA).  UVA Journal of Medicine.  2009 December. 6:31-7.

Bellizzi A, Woodford R, Moskaluk C, Jones D, Kozower B, Stelow E.  Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers.  Am J Surg Pathol.  2009 November. 33(11):1608-14.
[Link]

Bellizzi A, Frankel W.  Colorectal cancer due to deficiency in DNA mismatch repair function: A review.  Adv Anat Pathol.  2009 November. 16(6):405-17.
[PubMed]

Bellizzi A, Frankel W.  Colorectal cancer due to deficiency in DNA mismatch repair function: a review.  Adv Anat Pathol.  2009 November. 16(6):405-17.
[Link]

Bellizzi A, Kahaleh M, Stelow E.  The assessment of specimens procured by endoscopic ampullectomy.  Am J Clin Pathol.  2009 October. 132(4):506-13.
[PubMed]

Demyttenaere S, Nau P, Henn M, Beck C, Zaruby J, Primavera M, Kirsch D, Miller J, Liu J, Bellizzi A, Melvin W.  Barbed suture for gastrointestinal closure: a randomized control trial.  Surg Innov.  2009 September. 16(3):237-42.
[Link]

Bellizzi A, Frankel W.  Pancreatic pathology - a practical review.  Lab Med.  2009 July. 40(7):417-426.

Bellizzi A, Bloomston M, Bellizzi S, Marsh W, Frankel W.  Assessment of prognostic factors in pancreatic ductal adenocarcinoma: Focus on the retroperitoneal margin.  J Clin Oncol.  2009 June 8. 27(15S):E15670.

Horvath J, Frankel W, Bellizzi A, Guenterberg K, Iwenofu O.  Correlation of Cks1 and p27kip1 with tumor biologic aggressiveness and survival in gastrointestinal stromal tumor.  J Clin Oncol.  2009 June 8. 27(15S):e15549.

Bellizzi A, Stelow E.  Pancreatic cytopathology: a practical approach and review.  Arch Pathol Lab Med.  2009 March. 133(3):388-404.
[Link]

Bellizzi A, Bloomston M, Bellizzi S, Marsh W, Frankel W.  Assessment of prognostic factors in pancreatic ductal adenocarcinoma: Focus on the retroperitoneal margin.  2009 American Society of Clinical Oncology Annual Meeting.  2009. 

Bellizzi A, Bloomston M, Bellizzi S, Iwenofu O, Frankel W.  Assessment of the p27/Skp2/Cks1 axis in pancreatic ductal adenocarcinoma and ampullary adenocarcinoma.  2009 United States and Canadian Academy of Pathology Annual Meeting.  2009. 

Horvath J, Frankel W, Bellizzi A, Guenterberg K, Iwenofu O.  Correlation of Cks1 and p27kip1 with tumor biologic aggressiveness and survival in gastrointestinal stromal tumor.  2009 American Society of Clinical Oncology Annual Meeting.  2009. 

Zhou X, Frankel W, Bloomston M, Iwenofu O, Bellizzi A.  Frequent aberrant activation of the PI3K/Akt/mTOR pathway in pancreatic endocrine tumors.  2009 United States and Canadian Academy of Pathology Annual Meeting.  2009. 

Bellizzi A, Iwenofu O, Zhou X, Bloomston M, Frankel W.  Frequent activation of the mTOR pathway in pancreatic ductal adenocarcinoma.  2009 United States and Canadian Academy of Pathology Annual Meeting.  2009. 

Yearsley M, Bellizzi A, South C, Hampel H, Marsh W, Frankel W.  Routine mismatch repair protein immunostaining in colorectal carcinomas-equivocal MSH6 staining is a challenge.  2009 United States and Canadian Academy of Pathology Annual Meeting.  2009. 

Rock J, Bellizzi A, Marsh W, Frankel W.  Serrated appendiceal lesions: A morphologic and immunohistochemical appraisal.  2009 College of American Pathologists Annual Meeting.  2009. 

Lisle T, Gazoni L, Fernandez L, Sharma A, Bellizzi A, Schifflett G, Laubach V, Kron I.  Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation.  J Thorac Cardiovasc Surg.  2008 November. 136(5):1280-7; discussion 1287-8.
[Link]

Bellizzi A, Mills S.  Collagenous crystalloids in myoepithelial carcinoma: report of a case and review of the literature.  Am J Clin Pathol.  2008 September. 130(3):355-62.
[Link]

Kerr S, Bellizzi A, Stelow E, Frierson H, Policarpio-Nicolas M.  Initial assessment of fine-needle aspiration specimens by telepathology: validation for use in pathology resident-faculty consultations.  Am J Clin Pathol.  2008 September. 130(3):409-13.
[Link]

Bourne T, Bellizzi A, Stelow E, Loy A, Levine P, Wick M, Mills S.  p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract.  Am J Clin Pathol.  2008 August. 130(2):213-8.
[Link]

Stelow E, Bellizzi A, Taneja K, Mills S, Legallo R, Kutok J, Aster J, French C.  NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.  Am J Surg Pathol.  2008 June. 32(6):828-34.
[Link]

Bellizzi A, Bourne T, Mills S, Stelow E.  The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.  Am J Clin Pathol.  2008 March. 129(3):367-76.
[Link]

Bellizzi A, Legallo R, Iezzoni J.  Cytokeratin 7 hepatocyte immunoreactivity in chronic allograft rejection.  2008 United States and Canadian Academy of Pathology Annual Meeting.  2008. 

Bellizzi A, Woodford R, Stelow E.  Investigation of the molecular mechanism of esohpageal basaloid squamous cell carcinoma.  2008 United States and Canadian Academy of Pathology Annual Meeting.  2008. 

Lisle T, Fernandez L, Gazoni L, Sharma A, Bellizzi A, Linden J, Laubach V, Kron I.  Lung injury after cardiopulmonary bypass is attenuated by adenosine A2A receptor activation.  2008 American Association for Thoracic Surgery Annual Meeting.  2008. 

Woodford R, Hunt J, Bellizzi A, Zhang X, Mills S, Stelow E.  Papillary oncocytic neoplasms of the thyroid.  2008 United States and Canadian Academy of Pathology Annual Meeting.  2008. 

Kerr S, Bellizzi A, Stelow E, Policarpio-Nicholas M.  Preliminary assessment of fine needle aspiration specimens by telepathology: Validation for use in pathology resident and faculty consultations.  2008 United States and Canadian Academy of Pathology Annual Meeting.  2008. 

Bellizzi A, Bruzzi C, French C, Stelow E.  The cytologic features of NUT midline carcinoma.  2008 American Society of Cytopathology Annual Meeting.  2008. 

Stelow E, Bellizzi A, Mills S, Kutok J, Aster J, Legallo R, French C.  Undifferentiated carcinomas of the upper aerodigestive tract associated with NUT rearrangements.  2008 United States and Canadian Academy of Pathology Anual Meeting.  2008. 

Gazoni L, Laubach V, Mulloy D, Bellizzi A, Unger E, Linden J, Ellman P, Lisle T, Kron I.  Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion.  J Thorac Cardiovasc Surg.  2008 January. 135(1):156-65.
[Link]

Sharma P, Taigen T, Bellizzi A, Townsend G.  Sinuorbital zygomycosis complicated by diabetic ketoacidosis.  UVA Journal of Medicine.  2007 March. 1:28-32.

Gazoni L, Laubach V, Mulloy D, Bellizzi A, Unger E, Linden J, Ellman P, Lisle T, Kron I.  Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion.  2007 American Association for Thoroacic Surgery (AATS) Annual Meeting.  2007. 

Bellizzi A, Bourne T, Mills S, Stelow E.  Immunohistochemistry of molecular markers in sinonasal undifferentiated carcinomas.  2007 United States and Canadian Academy of Pathology Annual Meeting.  2007. 

Stelow E, Safo T, Pambuccian S, Bauer T, Stokes J, Bellizzi A, Adams R, Moskaluk C.  Mucus extravasation in pancreatic intraepithelial mucinous neoplasms (IPMNs and MCNs): a finding not to be confused with invasive adenocarcinoma.  2007 United States and Canadian Academy of Pathology Annual Meeting.  2007. 

Bellizzi A, Bellizzi S, Kahaleh M, Stelow E.  The assessment of specimens produred by endoscopic ampullectomy.  2007 United States and Canadian Academy of Pathology Annual Meeting.  2007. 

Bellizzi A, Bourne T, Mills S, Stelow E.  The cytology of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.  2007 American Society of Cytopathology Annual Meeting.  2007. 

Bellizzi A, Moskaluk C, Stelow E.  Mismatch repair protein deficiency and precursor intraepithelial serration in colorectal adenocarcinomas.  USCAP Annual Meeting.  2006. 

Lee L, Szafranska-Schwarzbach A, Wylie D, Doyle L, Bellizzi A, Kadiyala V, Suleiman S, Banks P, Andruss B, Conwell D.  Investigating MicroRNA expression profiles in pancreatic cystic neoplasms.  Clin Transl Gastroenterol.  5:e47.
[PubMed]

Bellizzi A.  Practical pancreatic pathology. 

Date Last Modified: 06/30/2014 - 10:40:22